Gastrointestinal diseases
Conditions
Interventions
Levobupivacaine group:none
Morphine group:add some dose of morphine to levobupivacaine
Dexmedetomidine group:add some dose of morphine to levobupivacaine
Sponsors
Second affiliated Hospital, Harbin Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: American Society of Anaesthesiology Physical Status I/II patients undergoing colorectal operation and agreed to sign the informed consent of patients.
Exclusion criteria
Exclusion criteria: None of the subjects included had neurologic or psychiatric disease, known allergy to local anaesthetic, a history of gastrointestinal motility disorders, renal or hepatic insufficiency, bleeding or coagulation test abnormalities, or were receiving anticoagulant.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| postoperative pain score;The postoperative first flatus time;The postoperative first feces time;The total dose of postoperative analgesic;The time to the first postoperative analgesi; | — |
Secondary
| Measure | Time frame |
|---|---|
| Side-effects related to dexmedetomidine and morphi;vital signs during the first 6 hours after operati; | — |
Countries
China
Contacts
Public ContactCui Xiao-Guang
Outcome results
None listed